43 results
Page 2 of 3
8-K
EX-1.1
gjuhxunq0xmn9
27 Nov 19
X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class B Warrants
5:18pm
424B5
e1eljx
27 Nov 19
Prospectus supplement for primary offering
12:00am
424B5
0nm967f
25 Nov 19
Prospectus supplement for primary offering
4:19pm
8-K/A
EX-10.8
n609ghzj81gut90
13 May 19
Financial Statements and Exhibits
4:58pm
8-K
EX-1.1
nkxp0
15 Apr 19
X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants
4:41pm
424B5
8btf2 2lav4
15 Apr 19
Prospectus supplement for primary offering
4:38pm
424B5
h0ssgwj1ej
12 Apr 19
Prospectus supplement for primary offering
6:05am
8-K
EX-10.8
tbsd vv77
13 Mar 19
X4 Pharmaceuticals Completes Merger with Arsanis
5:28pm
S-4/A
z9n8522e8n
13 Feb 19
Registration of securities issued in business combination transactions (amended)
4:44pm
S-3
bsovir
25 Jan 19
Shelf registration
5:04pm
S-4
y0egh
20 Dec 18
Registration of securities issued in business combination transactions
5:14pm
8-K
EX-2.1
5ure8rd3k
27 Nov 18
Entry into a Material Definitive Agreement
7:10am
425
EX-2.1
nj7fxihg25rjjcy9ry
27 Nov 18
Business combination disclosure
7:08am